サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1710948

植え込み型神経刺激装置の世界市場レポート 2025年

Implantable Neurostimulation Devices Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
植え込み型神経刺激装置の世界市場レポート 2025年
出版日: 2025年04月03日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

植え込み型神経刺激装置の市場規模は今後数年で急成長が見込まれます。2029年には年間平均成長率（CAGR）10.8％で145億3,000万米ドルに成長します。予測期間の成長は、神経疾患の有病率の上昇、生活習慣病の有病率の上昇、意識の高まり、脊髄損傷の増加、ヘルスケア支出の増加に起因しています。予測期間の主な動向には、センシング技術、神経刺激技術の進歩の増加、技術的に高度な製品、クローズドループシステムの組み込み、ワイヤレス技術の統合などがあります。

神経疾患の有病率の増加は、植え込み型神経刺激装置市場の今後の成長を促進すると予測されています。神経障害とは、神経系の構造や機能に影響を与える病態のことで、麻痺、発作、認知障害などさまざまな症状を引き起こします。高血圧、発育異常、外傷や損傷などの要因は、これらの障害の発見率を高める一因となっています。植え込み型神経刺激装置は、神経活動を調節し、他の治療が無効または不十分であると判明した場合に症状を緩和するために利用されます。例えば、米国を拠点とする非営利団体であるアルツハイマー病協会（Alzheimer's Association）は、2024年には65歳以上の米国人が約690万人、そのうち73％が75歳以上のアルツハイマー病患者であると報告しています。この数字は2050年までに1,270万人に増加すると予測されています。その結果、神経疾患の有病率の上昇は、植え込み型神経刺激装置市場の成長を促進すると予想されます。

植え込み型神経刺激装置市場の主なプレイヤーは、慢性疼痛状態に対処するために脊髄刺激（SCS）システムなどの先進技術を開発しています。SCSシステムは、電気インパルスを使用して脊髄の神経活動を調節する医療機器であり、その他の治療がうまくいかない場合に痛みを緩和し、患者のQOLを向上させる。例えば、2022年12月、米国の医療機器メーカーであるアボット社は、エテルナ脊髄刺激（SCS）システムのFDA承認を取得しました。エテルナSCSは、市場で最も小型の充電式植込み型脊髄刺激装置で、最高の快適性を目指して設計されています。アボット社のBurstDR刺激技術を搭載しており、自然な脳の発火パターンを再現して痛みの緩和を強化し、従来のうずくような刺激よりも87％の患者に好まれています。エテルナは、Xtendエネルギー技術により年間5回の充電で済み、TotalScan技術により全身MRI検査に対応します。また、交換することなく将来の進歩に適応可能です。アボット社のモバイルアプリとの統合により、iPhoneデバイスでバッテリー残量と充電状態をリアルタイムで追跡できます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界植え込み型神経刺激装置 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界の植え込み型神経刺激装置市場：成長率分析
  • 世界の植え込み型神経刺激装置市場の実績：規模と成長, 2019-2024
  • 世界の植え込み型神経刺激装置市場の予測：規模と成長, 2024-2029, 2034F
  • 世界植え込み型神経刺激装置総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の植え込み型神経刺激装置市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 脊髄刺激療法（SCS）
  • 胃電気刺激（GES）
  • 脳深部刺激療法（DBS）
  • 仙骨神経刺激（SNS）
  • 迷走神経刺激（VNS）
  • その他のタイプ
  • 世界の植え込み型神経刺激装置市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 疼痛管理
  • パーキンソン病
  • 尿失禁および便失禁
  • てんかん
  • 胃不全麻痺
  • その他の用途
  • 世界の植え込み型神経刺激装置市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院
  • クリニック
  • 外来手術センター
  • 世界の植え込み型神経刺激装置市場脊髄刺激（SCS）のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 充電式SCSデバイス
  • 充電式ではないSCSデバイス
  • 世界の植え込み型神経刺激装置市場胃電気刺激（GES）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 埋め込み型胃刺激装置
  • 調節可能な胃刺激装置
  • 世界の植え込み型神経刺激装置市場、脳深部刺激療法（DBS）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 運動障害のためのDBS装置
  • 精神疾患のためのDBS装置
  • 世界の植え込み型神経刺激装置市場仙骨神経刺激（SNS）のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 尿失禁のためのSNSデバイス
  • 便失禁のためのSNSデバイス
  • 世界の植え込み型神経刺激装置市場迷走神経刺激（VNS）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • てんかん治療用VNSデバイス
  • うつ病のためのVNSデバイス
  • 世界の植え込み型神経刺激装置市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 末梢神経刺激（PNS）
  • 皮質刺激装置
  • 新しい神経刺激技術

第7章 地域別・国別分析

  • 世界の植え込み型神経刺激装置市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の植え込み型神経刺激装置市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 植え込み型神経刺激装置市場：競合情勢
  • 植え込み型神経刺激装置市場：企業プロファイル
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Dignity Health Overview, Products and Services, Strategy and Financial Analysis
    • St. Jude Medical LLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • LivaNova PLC
  • Nevro Corp.
  • Axonics Inc.
  • NeuroPace Inc.
  • Bioness Inc.
  • Saluda Medical Pty Ltd.
  • SceneRay Co. Ltd.
  • NeuroMetrix Inc.
  • CURE Epilepsy
  • Synapse Biomedical Inc.
  • NeuroSigma Inc.
  • Nuvectra Corporation
  • MicroTransponder Inc.
  • Pain Management NYC
  • Curonix LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 植え込み型神経刺激装置市場2029：新たな機会を提供する国
  • 植え込み型神経刺激装置市場2029：新たな機会を提供するセグメント
  • 植え込み型神経刺激装置市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r31973

Implantable neurostimulation devices are medical devices designed to deliver electrical stimulation to specific areas of the nervous system to treat various neurological and psychological conditions. These devices are surgically implanted into the body to modulate nerve activity, offering a sophisticated approach for managing conditions that may not respond adequately to medication alone, thereby enhancing patients' quality of life.

The primary types of implantable neurostimulation devices include spinal cord stimulation (SCS), gastric electric stimulation (GES), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS), and others. Spinal cord stimulation (SCS) therapy uses mild electrical currents to block pain signals from reaching the brain, providing effective management for chronic pain conditions. These devices are applied in treating pain management, Parkinson's disease, urinary and fecal incontinence, epilepsy, gastroparesis, and other conditions. They are used by various end-users, including hospitals, clinics, and ambulatory surgical centers.

The implantable neurostimulation devices market research report is one of a series of new reports from The Business Research Company that provides implantable neurostimulation devices market statistics, including implantable neurostimulation devices industry global market size, regional shares, competitors with a implantable neurostimulation devices market share, detailed implantable neurostimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the implantable neurostimulation devices industry. This implantable neurostimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable neurostimulation devices market size has grown rapidly in recent years. It will grow from $8.68 $ billion in 2024 to $9.64 $ billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to increasing demand for non-pharmacological treatments, growing demand for minimally invasive procedures, growing geriatric population, increasing the wide range of psychiatric disorders, and increasing incidence of chronic diseases.

The implantable neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $14.53 $ billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to rising prevalence of neurological disorders, rise in prevalence of lifestyle diseases, rising awareness, increase in spinal cord injuries, and increasing healthcare expenditure. Major trends in the forecast period include sensing technology, increasing advances in neurostimulation technologies, technologically advanced products, incorporating closed-loop systems, and integrating wireless technology.

The increasing prevalence of neurological disorders is anticipated to drive the growth of the implantable neurostimulation device market in the future. Neurological disorders are conditions that impact the structure or function of the nervous system, leading to a range of symptoms such as paralysis, seizures, and cognitive impairments. Factors such as high blood pressure, developmental abnormalities, and trauma or injury contribute to higher detection rates of these disorders. Implantable neurostimulation devices are utilized to modulate nerve activity and alleviate symptoms when other treatments prove ineffective or insufficient. For example, in 2024, the Alzheimer's Association, a US-based non-profit organization, reported that approximately 6.9 million Americans aged 65 and older are living with Alzheimer's disease, with 73% being 75 years or older. This figure is projected to increase to 12.7 million by 2050. Consequently, the rising prevalence of neurological disorders is expected to propel the growth of the implantable neurostimulation device market.

Key players in the implantable neurostimulation devices market are developing advanced technologies, such as spinal cord stimulation (SCS) systems, to address chronic pain conditions. An SCS system is a medical device that uses electrical impulses to modulate nerve activity in the spinal cord, providing pain relief and improving patient quality of life when other treatments fail. For instance, in December 2022, Abbott, a U.S.-based medical device company, received FDA approval for the Eterna spinal cord stimulation (SCS) system. The Eterna SCS is the smallest rechargeable implantable spinal cord stimulator on the market, designed for maximum comfort. It features Abbott's BurstDR stimulation technology, which replicates natural brain firing patterns for enhanced pain relief and is preferred by 87% of patients over traditional tingling stimulation. Eterna requires as few as five recharges annually due to Xtend energy technology and supports full-body MRI scans with TotalScan technology. It is also adaptable to future advancements without replacement. Abbott's mobile app integration allows real-time tracking of battery life and charging status on iPhone devices.

In September 2023, Amber Therapeutics, a UK-based provider of neuromodulation therapies, acquired Bioinduction for an undisclosed amount. This acquisition gives Amber access to valuable hardware, expertise, and manufacturing experience, accelerating the development and commercialization of Amber-UI. Bioinduction is a UK-based manufacturer specializing in implantable neurostimulation devices.

Major companies operating in the implantable neurostimulation devices market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Dignity Health, St. Jude Medical LLC, LivaNova PLC, Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., CURE Epilepsy, Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Pain Management NYC, Curonix LLC

North America was the largest region in the implantable neurostimulation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable neurostimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable neurostimulation devices market consists of sales of responsive neurostimulation systems, peripheral nerve stimulation systems, cerebral spinal fluid shunt systems and electroceutical devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Neurostimulation Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable neurostimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable neurostimulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable neurostimulation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Spinal Cord Stimulation (SCS); Gastric Electric Stimulation (GES); Deep Brain Stimulation (DBS); Sacral Nerve Stimulation (SNS); Vagus Nerve Stimulation (VNS); Other Types
  • 2) By Application: Pain Management; Parkinson's Disease; Urinary And Fecal Incontinence; Epilepsy; Gastroparesis; Other Applications
  • 3) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Spinal Cord Stimulation (SCS): Rechargeable SCS Devices; Non-Rechargeable SCS Devices
  • 2) By Gastric Electric Stimulation (GES): Implantable Gastric Stimulators; Adjustable Gastric Stimulators
  • 3) By Deep Brain Stimulation (DBS): DBS Devices for Movement Disorders; DBS Devices for Psychiatric Disorders
  • 4) By Sacral Nerve Stimulation (SNS): SNS Devices for Urinary Incontinence; SNS Devices for Fecal Incontinence
  • 5) By Vagus Nerve Stimulation (VNS): VNS Devices for Epilepsy; VNS Devices for Depression
  • 6) By Other Types: Peripheral Nerve Stimulation (PNS); Cortical Stimulation Devices; Novel Neurostimulation Technologies
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; Dignity Health; St. Jude Medical LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Neurostimulation Devices Market Characteristics

3. Implantable Neurostimulation Devices Market Trends And Strategies

4. Implantable Neurostimulation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Implantable Neurostimulation Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Neurostimulation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Neurostimulation Devices Market Growth Rate Analysis
  • 5.4. Global Implantable Neurostimulation Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Neurostimulation Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Neurostimulation Devices Total Addressable Market (TAM)

6. Implantable Neurostimulation Devices Market Segmentation

  • 6.1. Global Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spinal Cord Stimulation (SCS)
  • Gastric Electric Stimulation (GES)
  • Deep Brain Stimulation (DBS)
  • Sacral Nerve Stimulation (SNS)
  • Vagus Nerve Stimulation (VNS)
  • Other Types
  • 6.2. Global Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pain Management
  • Parkinson's Disease
  • Urinary And Fecal Incontinence
  • Epilepsy
  • Gastroparesis
  • Other Applications
  • 6.3. Global Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • 6.4. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Spinal Cord Stimulation (SCS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rechargeable SCS Devices
  • Non-Rechargeable SCS Devices
  • 6.5. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Gastric Electric Stimulation (GES), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Gastric Stimulators
  • Adjustable Gastric Stimulators
  • 6.6. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Deep Brain Stimulation (DBS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • DBS Devices for Movement Disorders
  • DBS Devices for Psychiatric Disorders
  • 6.7. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Sacral Nerve Stimulation (SNS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • SNS Devices for Urinary Incontinence
  • SNS Devices for Fecal Incontinence
  • 6.8. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Vagus Nerve Stimulation (VNS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • VNS Devices for Epilepsy
  • VNS Devices for Depression
  • 6.9. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Peripheral Nerve Stimulation (PNS)
  • Cortical Stimulation Devices
  • Novel Neurostimulation Technologies

7. Implantable Neurostimulation Devices Market Regional And Country Analysis

  • 7.1. Global Implantable Neurostimulation Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Neurostimulation Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Neurostimulation Devices Market

  • 8.1. Asia-Pacific Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Neurostimulation Devices Market

  • 9.1. China Implantable Neurostimulation Devices Market Overview
  • 9.2. China Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Neurostimulation Devices Market

  • 10.1. India Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Neurostimulation Devices Market

  • 11.1. Japan Implantable Neurostimulation Devices Market Overview
  • 11.2. Japan Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Neurostimulation Devices Market

  • 12.1. Australia Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Neurostimulation Devices Market

  • 13.1. Indonesia Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Neurostimulation Devices Market

  • 14.1. South Korea Implantable Neurostimulation Devices Market Overview
  • 14.2. South Korea Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Neurostimulation Devices Market

  • 15.1. Western Europe Implantable Neurostimulation Devices Market Overview
  • 15.2. Western Europe Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Neurostimulation Devices Market

  • 16.1. UK Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Neurostimulation Devices Market

  • 17.1. Germany Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Neurostimulation Devices Market

  • 18.1. France Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Neurostimulation Devices Market

  • 19.1. Italy Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Neurostimulation Devices Market

  • 20.1. Spain Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Neurostimulation Devices Market

  • 21.1. Eastern Europe Implantable Neurostimulation Devices Market Overview
  • 21.2. Eastern Europe Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Neurostimulation Devices Market

  • 22.1. Russia Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Neurostimulation Devices Market

  • 23.1. North America Implantable Neurostimulation Devices Market Overview
  • 23.2. North America Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Neurostimulation Devices Market

  • 24.1. USA Implantable Neurostimulation Devices Market Overview
  • 24.2. USA Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Neurostimulation Devices Market

  • 25.1. Canada Implantable Neurostimulation Devices Market Overview
  • 25.2. Canada Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Neurostimulation Devices Market

  • 26.1. South America Implantable Neurostimulation Devices Market Overview
  • 26.2. South America Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Neurostimulation Devices Market

  • 27.1. Brazil Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Neurostimulation Devices Market

  • 28.1. Middle East Implantable Neurostimulation Devices Market Overview
  • 28.2. Middle East Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Neurostimulation Devices Market

  • 29.1. Africa Implantable Neurostimulation Devices Market Overview
  • 29.2. Africa Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Neurostimulation Devices Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Neurostimulation Devices Market Competitive Landscape
  • 30.2. Implantable Neurostimulation Devices Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Dignity Health Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. St. Jude Medical LLC Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Neurostimulation Devices Market Other Major And Innovative Companies

  • 31.1. LivaNova PLC
  • 31.2. Nevro Corp.
  • 31.3. Axonics Inc.
  • 31.4. NeuroPace Inc.
  • 31.5. Bioness Inc.
  • 31.6. Saluda Medical Pty Ltd.
  • 31.7. SceneRay Co. Ltd.
  • 31.8. NeuroMetrix Inc.
  • 31.9. CURE Epilepsy
  • 31.10. Synapse Biomedical Inc.
  • 31.11. NeuroSigma Inc.
  • 31.12. Nuvectra Corporation
  • 31.13. MicroTransponder Inc.
  • 31.14. Pain Management NYC
  • 31.15. Curonix LLC

32. Global Implantable Neurostimulation Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Neurostimulation Devices Market

34. Recent Developments In The Implantable Neurostimulation Devices Market

35. Implantable Neurostimulation Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Neurostimulation Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Neurostimulation Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Neurostimulation Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer